The use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin
Tuberculosis (TB) remains a large-scale public health problem. Key global priorities for TB care and control include improving case-detection and detecting cases earlier, including cases of smear-negative disease. This document updates existing WHO policy on the use of molecular LPAs for detecting MTBC a...
Técnicas de Sonda Molecular, Rifamicinas/uso terapéutico, Isoniazida/uso terapéutico, Tuberculosis Resistente a Múltiples Medicamentos/diagnóstico, Antituberculosos/uso terapéutico, Isoniazida/farmacología, Rifampin/farmacología, Mycobacterium tuberculosis/efectos de los fármacos, Farmacorresistencia Bacteriana, Reproducibilidad de los Resultados